Neogen Corp (NEOG) stock
NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$11.08+0.18 (+1.65%)
Close on Nov 18, 2026Market cap $2.42BP/E –Yield –
Neogen market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Neogen's market cap was $2.53B on Nov 11, 2026, against $1.30B a year earlier. Over the last 5 years it ranged from $1.01B to $5.01B, with a median of $2.67B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.53B | +66.7% |
| 2025 | Dec 31, 2025 | $1.52B | -42.3% |
| 2024 | Dec 31, 2024 | $2.63B | -39.5% |
| 2023 | Dec 29, 2023 | $4.35B | +164.9% |
| 2022 | Dec 30, 2022 | $1.64B | -66.4% |
| 2021 | Dec 31, 2021 | $4.88B | +16.1% |
| 2020 | Dec 31, 2020 | $4.21B | +22.9% |
| 2019 | Dec 31, 2019 | $3.42B | +15.4% |
| 2018 | Dec 31, 2018 | $2.96B | -5.7% |
| 2017 | Dec 29, 2017 | $3.14B | -5.3% |
| 2016 | Dec 30, 2016 | $3.32B | +17.8% |
| 2015 | Dec 31, 2015 | $2.82B | +15.4% |
| 2014 | Dec 31, 2014 | $2.44B | +10.2% |
| 2013 | Dec 31, 2013 | $2.22B | +54.1% |
| 2012 | Dec 31, 2012 | $1.44B | +50.6% |
| 2011 | Dec 30, 2011 | $954.91M | -24.4% |
| 2010 | Dec 31, 2010 | $1.26B | – |
See a number that looks wrong?